In November 2018, the legal status of cannabis was amended to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need.
To support this change, NICE (National Institute for Health and Care Excellence) has reviewed evidence for the benefits and costs of cannabis-based medicinal products and drawn up guidance for health professionals and the public.
The draft guideline acknowledges that, for people with MS, Sativex can be an effective treatment for MS spasticity which has not responded to other therapies. However, Sativex is not recommended because, at its current list price, it is not considered to be cost-effective. The calculations used to reach this decision indicated that Sativex would be cost effective if the list price was reduced from £375 to £188 per pack.
The draft NICE guideline also does not recommend the use of cannabis-based medicinal products for people with chronic pain, including people with MS experiencing nerve pain.
The MS Trust is hugely disappointed that, once again, Sativex has been turned down because it is too expensive for the NHS.
- Paru Naik, Health Professional Programme Director, MS Trust
The MS Trust is reviewing the draft guideline from NICE and we will respond to the consultation process.
We encourage people to add their own comments on this draft guideline; you can do so via the NICE website by 5pm on 5 September 2019. The final guideline is expected to be published in November 2019.
Move it for MS Nick's story
7 Oct 2021 - 00:00
Nick, was diagnosed with relapsing remitting multiple sclerosis at the start of the first lockdown. In this story we talk to him about how he coped with his diagnosis and how running helps him with his MS.
David's diary - Inclusion and diversity, where are we now?
6 Oct 2021 - 00:00
Just over a year ago we published a diary entry about Inclusivity and Diversity at the MS Trust. In this piece we take a look at what's changed since then and what we still need to do.
Flu season 2021
4 Oct 2021 - 00:00
This year is likely to involve a bigger flu vaccination programme in the UK, including for people with multiple sclerosis (MS), due to the circulation of Covid-19 at the same time. Here we discuss who's eligible for a flu jab on the NHS and how to get one.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.